Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.

Pérez Brandán C, Mesías AC, Parodi C, Cimino RO, Pérez Brandán C, Diosque P, Basombrío MÁ.

BMC Infect Dis. 2017 Nov 25;17(1):732. doi: 10.1186/s12879-017-2834-6.

2.

TcI Isolates of Trypanosoma cruzi Exploit the Antioxidant Network for Enhanced Intracellular Survival in Macrophages and Virulence in Mice.

Zago MP, Hosakote YM, Koo SJ, Dhiman M, Piñeyro MD, Parodi-Talice A, Basombrio MA, Robello C, Garg NJ.

Infect Immun. 2016 May 24;84(6):1842-1856. doi: 10.1128/IAI.00193-16. Print 2016 Jun.

3.

American tegumentary leishmaniasis: T-cell differentiation profile of cutaneous and mucosal forms-co-infection with Trypanosoma cruzi.

Parodi C, García Bustos MF, Barrio A, Ramos F, González Prieto AG, Mora MC, Baré P, Basombrío MA, de Elizalde de Bracco MM.

Med Microbiol Immunol. 2016 Aug;205(4):353-69. doi: 10.1007/s00430-016-0455-0. Epub 2016 Apr 4.

PMID:
27040974
4.

[Erratum: More about miltefosine in the treatment of mucosal leishmaniasis].

García Bustos MF, Barrio A, Basombrío MA.

Medicina (B Aires). 2015;75(2):131. Spanish. No abstract available.

PMID:
26738201
5.

Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases.

García Bustos MF, González-Prieto G, Ramos F, Mora MC, Hashiguchi Y, Parodi C, Basombrío MA, Moreno S, Monroig S, Beckar J, Jaime D, Sajama J, Yeo M, Marco JD, Locatelli FM, Barrio A.

Acta Trop. 2016 Feb;154:125-32. doi: 10.1016/j.actatropica.2015.11.008. Epub 2015 Nov 21.

PMID:
26611809
6.

Genetic and clinical characterization of canine leishmaniasis caused by Leishmania (Leishmania) infantum in northeastern Argentina.

Barroso PA, Nevot MC, Hoyos CL, Locatelli FM, Lauthier JJ, Ruybal P, Cardozo RM, Russo PD, Vassiliades CN, Mora MC, Estévez JO, Hashiguchi Y, Korenaga M, Basombrío MA, Marco JD.

Acta Trop. 2015 Oct;150:218-23. doi: 10.1016/j.actatropica.2015.08.007. Epub 2015 Aug 13.

PMID:
26277067
7.

Visceral Leishmaniasis Caused by Leishmania infantum in Salta, Argentina: Possible Reservoirs and Vectors.

Barroso PA, Marco JD, Locatelli FM, Cardozo RM, Hoyos CL, Mora MC, García Bustos MF, López-Quiroga I, Mimori T, Gentile AG, Barrio AB, Korenaga M, Hashiguchi Y, Basombrío MA.

Am J Trop Med Hyg. 2015 Aug;93(2):334-9. doi: 10.4269/ajtmh.14-0267. Epub 2015 Jun 8.

8.

[More about miltefosine in the treatment of mucosal leishmaniasis].

Bustos MF, Barrio A, Basombrío MÁ.

Medicina (B Aires). 2015;75(2):131. Spanish. No abstract available. Erratum in: Medicina (B Aires). 2015;75(2):131.

9.

Experimental evidence of biological interactions among different isolates of Trypanosoma cruzi from the Chaco Region.

Ragone PG, Pérez Brandán C, Monje Rumi M, Tomasini N, Lauthier JJ, Cimino RO, Uncos A, Ramos F, Alberti D'Amato AM, Basombrío MA, Diosque P.

PLoS One. 2015 Mar 19;10(3):e0119866. doi: 10.1371/journal.pone.0119866. eCollection 2015.

10.

Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.

Sánchez-Valdéz FJ, Pérez Brandán C, Ferreira A, Basombrío MÁ.

Expert Rev Vaccines. 2015 May;14(5):681-97. doi: 10.1586/14760584.2015.989989. Epub 2014 Dec 11. Review.

PMID:
25496192
11.

Trypanosoma cruzi diversity in the Gran Chaco: mixed infections and differential host distribution of TcV and TcVI.

Monje-Rumi MM, Brandán CP, Ragone PG, Tomasini N, Lauthier JJ, Alberti D'Amato AM, Cimino RO, Orellana V, Basombrío MA, Diosque P.

Infect Genet Evol. 2015 Jan;29:53-9. doi: 10.1016/j.meegid.2014.11.001. Epub 2014 Nov 8.

PMID:
25445658
12.

[Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis].

Garcia Bustos MF, Barrio A, Parodi C, Beckar J, Moreno S, Basombrio MA.

Medicina (B Aires). 2014;74(5):371-7. Spanish.

13.

Hepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethylnitrofurazone: a comparison with Benznidazole.

Davies C, Dey N, Negrette OS, Parada LA, Basombrio MA, Garg NJ.

PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3231. doi: 10.1371/journal.pntd.0003231. eCollection 2014 Oct.

14.

Preponderant clonal evolution of Trypanosoma cruzi I from Argentinean Chaco revealed by Multilocus Sequence Typing (MLST).

Tomasini N, Lauthier JJ, Monje Rumi MM, Ragone PG, Alberti D'Amato AM, Brandán CP, Basombrío MA, Diosque P.

Infect Genet Evol. 2014 Oct;27:348-54. doi: 10.1016/j.meegid.2014.08.003. Epub 2014 Aug 8.

PMID:
25111612
15.

In vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis.

García Bustos MF, Barrio A, Prieto GG, de Raspi EM, Cimino RO, Cardozo RM, Parada LA, Yeo M, Soto J, Uncos DA, Parodi C, Basombrío MA.

J Parasitol. 2014 Dec;100(6):840-7. doi: 10.1645/13-376.1.

PMID:
25014108
16.

A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.

Sánchez-Valdéz FJ, Pérez Brandán C, Ramírez G, Uncos AD, Zago MP, Cimino RO, Cardozo RM, Marco JD, Ferreira A, Basombrío MÁ.

PLoS Negl Trop Dis. 2014 Feb 13;8(2):e2696. doi: 10.1371/journal.pntd.0002696. eCollection 2014 Feb.

17.

Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units.

Rumi MM, Pérez Brandán C, Gil JF, D'Amato AM, Ragone PG, Lauthier JJ, Tomasini N, Cimino RO, Orellana V, Lacunza CD, Nasser JR, Basombrío MA, Diosque P.

Acta Trop. 2013 Oct;128(1):130-6. doi: 10.1016/j.actatropica.2013.07.003. Epub 2013 Jul 20.

PMID:
23880286
18.

Histologic and histomorphometric study of bone repair under acute Trypanosoma cruzi infection in rats.

Steimetz T, Gorustovich AA, Collet AM, Sanchez Negrette O, Segura MA, Basombrío MA, Guglielmotti MB.

Acta Odontol Latinoam. 2012;25(2):193-200.

19.

[Comparison of nucleic acid extraction efficiency using different commercial kits and qPCR. Effect of inhibitors].

Poma HR, Davies C, Gutiérrez Cacciabue D, Mora MC, Basombrío MÁ, Rajal VB.

Rev Argent Microbiol. 2012 Jul-Sep;44(3):144-9. Spanish.

20.

Trypanosoma cruzi carrying a monoallelic deletion of the calreticulin (TcCRT) gene are susceptible to complement mediated killing and defective in their metacyclogenesis.

Sánchez Valdéz FJ, Pérez Brandán C, Zago MP, Labriola C, Ferreira A, Basombrío MÁ.

Mol Immunol. 2013 Mar;53(3):198-205. doi: 10.1016/j.molimm.2012.08.001. Epub 2012 Sep 3.

PMID:
22954747
21.

Polymorphism-specific PCR enhances the diagnostic performance of American tegumentary leishmaniasis and allows the rapid identification of Leishmania species from Argentina.

Marco JD, Barroso PA, Mimori T, Locatelli FM, Tomatani A, Mora MC, Cajal SP, Nasser JR, Parada LA, Taniguchi T, Korenaga M, Basombrío MA, Hashiguchi Y.

BMC Infect Dis. 2012 Aug 15;12:191.

22.

Genetically attenuated Trypanosoma cruzi parasites as a potential vaccination tool.

Pérez Brandan C, Basombrío MÁ.

Bioengineered. 2012 Jul-Aug;3(4):242-6. doi: 10.4161/bioe.20680. Epub 2012 Jun 18.

23.

Biological behavior of different Trypanosoma cruzi isolates circulating in an endemic area for Chagas disease in the Gran Chaco region of Argentina.

Ragone PG, Pérez Brandán C, Padilla AM, Monje Rumi M, Lauthier JJ, Alberti D'Amato AM, Tomasini N, Cimino RO, Romero NM, Portelli M, Nasser JR, Basombrío MA, Diosque P.

Acta Trop. 2012 Sep;123(3):196-201. doi: 10.1016/j.actatropica.2012.05.003. Epub 2012 May 27.

PMID:
22643298
24.

Immunological correlates of cure in the first American cutaneous leishmaniasis patient treated by immunotherapy in Argentina. A case report.

García Bustos MF, Barrio AB, Parodi Ramoneda CM, Ramos F, Mora MC, Convit J, Basombrío MA.

Invest Clin. 2011 Dec;52(4):365-75.

PMID:
22523846
25.

Leishmania infantum and human visceral leishmaniasis, Argentina.

Barrio A, Parodi CM, Locatelli F, Mora MC, Basombrío MA, Korenaga M, Hashiguchi Y, García Bustos MF, Gentile A, Marco JD.

Emerg Infect Dis. 2012 Feb;18(2):354-5. doi: 10.3291/eid1802.110924. No abstract available.

26.

Candidate targets for Multilocus Sequence Typing of Trypanosoma cruzi: validation using parasite stocks from the Chaco Region and a set of reference strains.

Lauthier JJ, Tomasini N, Barnabé C, Rumi MM, D'Amato AM, Ragone PG, Yeo M, Lewis MD, Llewellyn MS, Basombrío MA, Miles MA, Tibayrenc M, Diosque P.

Infect Genet Evol. 2012 Mar;12(2):350-8. doi: 10.1016/j.meegid.2011.12.008. Epub 2011 Dec 22.

PMID:
22210092
27.

Knockout of the dhfr-ts gene in Trypanosoma cruzi generates attenuated parasites able to confer protection against a virulent challenge.

Perez Brandan C, Padilla AM, Xu D, Tarleton RL, Basombrio MA.

PLoS Negl Trop Dis. 2011 Dec;5(12):e1418. doi: 10.1371/journal.pntd.0001418. Epub 2011 Dec 13.

28.

Interest and limitations of Spliced Leader Intergenic Region sequences for analyzing Trypanosoma cruzi I phylogenetic diversity in the Argentinean Chaco.

Tomasini N, Lauthier JJ, Monje Rumi MM, Ragone PG, Alberti D'Amato AA, Pérez Brandan C, Cura CI, Schijman AG, Barnabé C, Tibayrenc M, Basombrío MA, Falla A, Herrera C, Guhl F, Diosque P.

Infect Genet Evol. 2011 Mar;11(2):300-7. doi: 10.1016/j.meegid.2010.10.020. Epub 2010 Nov 24.

PMID:
21111067
29.

Inheritance of resistance to pyrethroids in Triatoma infestans, the main Chagas disease vector in South America.

Cardozo RM, Panzera F, Gentile AG, Segura MA, Pérez R, Díaz RA, Basombrío MA.

Infect Genet Evol. 2010 Dec;10(8):1174-8. doi: 10.1016/j.meegid.2010.07.017. Epub 2010 Jul 30.

PMID:
20674788
30.

Hydroxymethylnitrofurazone is active in a murine model of Chagas' disease.

Davies C, Marino Cardozo R, Sánchez Negrette O, Mora MC, Chung MC, Basombrío MA.

Antimicrob Agents Chemother. 2010 Sep;54(9):3584-9. doi: 10.1128/AAC.01451-09. Epub 2010 Jun 21.

31.

Protective immunity against Trypanosoma cruzi.

Parodi C, Padilla AM, Basombrío MA.

Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:288-94.

32.

Enzymes of the antioxidant network as novel determiners of Trypanosoma cruzi virulence.

Piacenza L, Zago MP, Peluffo G, Alvarez MN, Basombrio MA, Radi R.

Int J Parasitol. 2009 Nov;39(13):1455-64. doi: 10.1016/j.ijpara.2009.05.010. Epub 2009 Jun 6.

33.

Evaluation of high efficiency gene knockout strategies for Trypanosoma cruzi.

Xu D, Brandán CP, Basombrío MA, Tarleton RL.

BMC Microbiol. 2009 May 11;9:90. doi: 10.1186/1471-2180-9-90.

34.

Congenital Chagas disease involves Trypanosoma cruzi sub-lineage IId in the northwestern province of Salta, Argentina.

Corrales RM, Mora MC, Negrette OS, Diosque P, Lacunza D, Virreira M, Brenière SF, Basombrio MA.

Infect Genet Evol. 2009 Mar;9(2):278-82. doi: 10.1016/j.meegid.2008.12.008. Epub 2008 Dec 31.

PMID:
19162237
35.

In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas' disease.

Boiani L, Davies C, Arredondo C, Porcal W, Merlino A, Gerpe A, Boiani M, Pacheco JP, Basombrío MA, Cerecetto H, González M.

Eur J Med Chem. 2008 Oct;43(10):2229-37. doi: 10.1016/j.ejmech.2007.12.016. Epub 2007 Dec 28.

PMID:
18255195
36.

Serological evaluation of specific-antibody levels in patients treated for chronic Chagas' disease.

Sánchez Negrette O, Sánchez Valdéz FJ, Lacunza CD, García Bustos MF, Mora MC, Uncos AD, Basombrío MA.

Clin Vaccine Immunol. 2008 Feb;15(2):297-302. Epub 2007 Dec 5.

37.
38.

In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivatives.

Porcal W, Hernández P, Boiani M, Aguirre G, Boiani L, Chidichimo A, Cazzulo JJ, Campillo NE, Paez JA, Castro A, Krauth-Siegel RL, Davies C, Basombrío MA, González M, Cerecetto H.

J Med Chem. 2007 Nov 29;50(24):6004-15. Epub 2007 Oct 26.

PMID:
17960923
39.

Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi.

Zago MP, Barrio AB, Cardozo RM, Duffy T, Schijman AG, Basombrío MA.

Infect Immun. 2008 Jan;76(1):443-51. Epub 2007 Oct 15.

40.

Trypanosoma cruzi: attenuation of virulence and protective immunogenicity after monoallelic disruption of the cub gene.

Barrio AB, Van Voorhis WC, Basombrío MA.

Exp Parasitol. 2007 Dec;117(4):382-9. Epub 2007 May 23.

PMID:
17624327
41.

The identification of sandfly species, from an area of Argentina with endemic leishmaniasis, by the PCR-based analysis of the gene coding for 18S ribosomal RNA.

Barroso PA, Marco JD, Kato H, Tarama R, Rueda P, Cajal SP, Basombrío MA, Korenaga M, Taranto NJ, Hashiguchi Y.

Ann Trop Med Parasitol. 2007 Apr;101(3):247-53.

PMID:
17362599
42.

Are cytochrome B gene sequencing and polymorphism-specific polymerase chain reaction as reliable as multilocus enzyme electrophoresis for identifying Leishmania spp. from Argentina?

Marco JD, Uezato H, Mimori T, Barroso PA, Korenaga M, Nonaka S, Basombrío MA, Taranto NJ, Hashiguchi Y.

Am J Trop Med Hyg. 2006 Aug;75(2):256-60.

PMID:
16896128
43.

Trypanosoma cruzi: infectivity modulation of a clone after passages through different hosts.

Pérez Brandán C, Padilla AM, Diosque P, Basombrío MA.

Exp Parasitol. 2006 Oct;114(2):89-93. Epub 2006 Mar 29.

PMID:
16564526
44.

Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology.

Mora MC, Sanchez Negrette O, Marco D, Barrio A, Ciaccio M, Segura MA, Basombrío MA.

J Parasitol. 2005 Dec;91(6):1468-73.

PMID:
16539033
45.

Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies.

Aguirre G, Boiani M, Cerecetto H, Fernández M, González M, León E, Pintos C, Raymondo S, Arredondo C, Pacheco JP, Basombrío MA.

Pharmazie. 2006 Jan;61(1):54-9.

PMID:
16454207
46.

High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina.

Sánchez Negrette O, Mora MC, Basombrío MA.

Pediatrics. 2005 Jun;115(6):e668-72.

PMID:
15930194
47.

Species assignation of Leishmania from human and canine American tegumentary leishmaniasis cases by multilocus enzyme electrophoresis in North Argentina.

Marco JD, Barroso PA, Calvopiña M, Kumazawa H, Furuya M, Korenaga M, Cajal SP, Mora MC, Rea MM, Borda CE, Basombrío MA, Taranto NJ, Hashiguchi Y.

Am J Trop Med Hyg. 2005 May;72(5):606-11.

PMID:
15891136
48.
49.

Chagas disease in rural areas of Chaco Province, Argentina: epidemiologic survey in humans, reservoirs, and vectors.

Diosque P, Padilla AM, Cimino RO, Cardozo RM, Negrette OS, Marco JD, Zacca R, Meza C, Juarez A, Rojo H, Rey R, Corrales RM, Nasser JR, Basombrío MA.

Am J Trop Med Hyg. 2004 Nov;71(5):590-3.

PMID:
15569789
50.

Multilocus enzyme electrophoresis analysis of Trypanosoma cruzi isolates from a geographically restricted endemic area for Chagas' disease in Argentina.

Diosque P, Barnabé C, Padilla AM, Marco JD, Cardozo RM, Cimino RO, Nasser JR, Tibayrenc M, Basombrío MA.

Int J Parasitol. 2003 Sep 15;33(10):997-1003.

PMID:
13129520

Supplemental Content

Loading ...
Support Center